The emerging role of CHI3L1 as a diagnostic marker and therapeutic target in allergic diseases and respiratory comorbidities
Open Access
- 8 August 2024
- journal article
- Published by Elsevier in Allergy Medicine
- Vol. 1, 100001
Abstract
No abstract availableThis publication has 105 references indexed in Scilit:
- Clinical characteristics of unvaccinated or incompletely vaccinated children with neurological manifestations due to SARS‐CoV‐2 Omicron infectionJournal of Medical Virology, 2023
- New therapeutic strategy for atopic dermatitis by targeting CHI3L1/ITGA5 axisClinical and Translational Medicine, 2022
- Anti‐Chi3L1 antibody suppresses lung tumor growth and metastasis through inhibition of M2 polarizationMolecular Oncology, 2021
- A small molecule targeting CHI3L1 inhibits lung metastasis by blocking IL‐13Rα2‐mediated JNK‐AP‐1 signalsMolecular Oncology, 2021
- Association between YKL-40 and asthma: a systematic meta-analysisSleep and Breathing, 2021
- Chitinase 3‐like 1 polymorphisms and risk of chronic obstructive pulmonary disease and asthma in a Chinese populationThe Journal of Gene Medicine, 2020
- Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibodyClinical Rheumatology, 2019
- Neutrophils as a Potential Source of Chitinase-3-like Protein 1 in Cystic FibrosisInflammation, 2018
- A repertoire of biomarkers helps in detection and assessment of therapeutic response in epithelial ovarian cancerMolecular and Cellular Biochemistry, 2013
- Molecular Characterization of the Gene for Human Cartilage gp-39 (CHI3L1), a Member of the Chitinase Protein Family and Marker for Late Stages of Macrophage DifferentiationGenomics, 1997